✦ LIBER ✦

Chronic dosing of phosphodiesterase type 5 inhibitors

✍ Scribed by Craig F. Donatucci

Publisher: Springer
Year: 2008
Tongue: English
Weight: 218 KB
Volume: 5
Category: Article
ISSN: 1548-3584
DOI: 10.1007/s11930-008-0012-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonurologic applications of phosphodiest

Nonurologic applications of phosphodiesterase type 5 inhibitors

✍ Rakesh C. Kukreja; Fadi N. Salloum; Lei Xi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 274 KB

Phosphodiesterase type 5 inhibitors and

Phosphodiesterase type 5 inhibitors and endothelial function

✍ Antonio Aversa; Roberto Bruzziches 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 146 KB

Phosphodiesterase type 5 inhibitors in p

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

Clinical update on phosphodiesterase typ

Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction

✍ Alberto Briganti; Andrea Salonia; Federico Deho’; Giuseppe Zanni; Luigi Barbieri 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Phosphodiesterase type 5 inhibitors for

Phosphodiesterase type 5 inhibitors for the treatment of female sexual function

✍ Kevin T. McVary 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 170 KB

Erectogenic effect of the selective phos

Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159

✍ Tae Young Oh; Kyung Koo Kang; Byoung Ok Ahn; Moohi Yoo; Won Bae Kim 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 614 KB